Hovione is an international company with over 55 years experience in API development and compliant manufacture. With four FDA inspected sites in the U.S., China, Ireland, and Portugal, the company makes available branded pharmaceutical customers services for the development and compliant manufacture of innovative new drugs, is able to support highly potent compounds and offers proprietary product development and licensing opportunities for drug products. The company also undertakes the formulation development and clinical supply of the final dosage form to Phase II. In the inhalation area, Hovione offers APIs for inhalation, dry-powder inhalation devices, particle engineering and inhalation formulation development. Learn more.